Literature DB >> 22562028

Comparative study of bone repair using porous hydroxyapatite/ β-tricalcium phosphate and xenograft scaffold in rabbits with tibia defect.

Zohreh Bagher1, Farzad Rajaei1, Mohammadali Shokrgozar2.   

Abstract

BACKGROUND: Bone tissue engineering requires materials that are biocompatible, mechanically suited for bone function, integrated with the host skeleton, and support osteoinduction of the implanted cells for new bone formation. The aim of this study was to compare the osteogenic potential of xenograft with hydroxyapatite/β- tricalcium phosphate (HA/β-TCP) scaffold.
METHODS: New Zealand rabbits (n = 9) were divided into 3 groups. Osteoblast cells were originally isolated from rabbit iliac crest and cultured in DMEM/F12. After creating a critical-sized defect (2 × 3 cm) in rabbit tibia bone, the defect was filled with an implant of HA/TCP with osteoblasts and xenograft in the hole of left (as control) and right tibia, respectively. The new bone formation and the development of bone union within the defect were evaluated by x-ray images and eosine and hematoxylin staining at 4, 8, and 12 weeks post-operation.
RESULTS: The bone partially formed in both groups was filled with osteoblast cultured on porous implants at 4 weeks. Over time, progressive bone regeneration was observed inside the pores. Moreover, a progressive vascular ingrowth and progressive integration with the host bone were obvious in xenograft when compared to HA/β-TCP. A good integration between the xenograft implants and the bone was observed radiographically and confirmed by histological section.
CONCLUSION: The result showed that the bone defect can be repaired using both synthetic and xenograft implants. However, the xenograft showed a better osteointegration as compared to HA/β-TCP scaffold.

Entities:  

Keywords:  Osteoblasts; Hydroxyapatite/β-Tricalcium phosphate; Bone tissue

Mesh:

Substances:

Year:  2012        PMID: 22562028      PMCID: PMC3614259          DOI: 10.6091/ibj.996.2012

Source DB:  PubMed          Journal:  Iran Biomed J        ISSN: 1028-852X


  29 in total

Review 1.  Clinical indications of calcium-phosphate biomaterials and related composites for orthopedic procedures.

Authors:  J E Block; M R Thorn
Journal:  Calcif Tissue Int       Date:  2000-03       Impact factor: 4.333

2.  Tissue engineers build new bone.

Authors:  R F Service
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

3.  Bone formation induced by calcium phosphate ceramics in soft tissue of dogs: a comparative study between porous alpha-TCP and beta-TCP.

Authors:  H Yuan; J D De Bruijn; Y Li; J Feng; Z Yang; K De Groot; X Zhang
Journal:  J Mater Sci Mater Med       Date:  2001-01       Impact factor: 3.896

Review 4.  The biology of bone grafting.

Authors:  Safdar N Khan; Frank P Cammisa; Harvinder S Sandhu; Ashish D Diwan; Federico P Girardi; Joseph M Lane
Journal:  J Am Acad Orthop Surg       Date:  2005 Jan-Feb       Impact factor: 3.020

5.  Resorption of, and bone formation from, new beta-tricalcium phosphate-monocalcium phosphate cements: an in vivo study.

Authors:  K Ohura; M Bohner; P Hardouin; J Lemaître; G Pasquier; B Flautre
Journal:  J Biomed Mater Res       Date:  1996-02

6.  [Determining the size of the specific surface of bone substitutes with gas adsorption].

Authors:  G Weibrich; R Trettin; S H Gnoth; H Götz; H Duschner; W Wagner
Journal:  Mund Kiefer Gesichtschir       Date:  2000-05

7.  Bone marrow-derived osteoblasts seeded into porous beta-tricalcium phosphate to repair segmental defect in canine's mandibula.

Authors:  Wei Wu; Xiaobin Chen; Tianqiu Mao; Fulin Chen; Xinghua Feng
Journal:  Ulus Travma Acil Cerrahi Derg       Date:  2006-10

8.  Beta-tricalcium phosphate (beta-TCP) graft combined with bone marrow stromal cells (MSCs) for posterolateral spine fusion.

Authors:  Hisaya Orii; Shinichi Sotome; Jiani Chen; Juyong Wang; Kenichi Shinomiya
Journal:  J Med Dent Sci       Date:  2005-03

9.  Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds.

Authors:  A S Goldstein; T M Juarez; C D Helmke; M C Gustin; A G Mikos
Journal:  Biomaterials       Date:  2001-06       Impact factor: 12.479

10.  Comparative histomorphometric and tomographic analysis of maxillary sinus floor augmentation in rabbits using autografts and xenografts.

Authors:  Cristina Miguel Sicca; Mauro Vinícius Corotti; Sílvia Helena Pereira Vergili Sgarbosa; Tania Mary Cestari; Marcelo Gusmão Paraíso Cavalcanti; Paulo Martins Ferreira; Rumio Taga; José Mauro Granjeiro
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2008-07       Impact factor: 3.368

View more
  5 in total

Review 1.  The current state of scaffolds for musculoskeletal regenerative applications.

Authors:  Benjamin D Smith; Daniel A Grande
Journal:  Nat Rev Rheumatol       Date:  2015-03-17       Impact factor: 20.543

Review 2.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

3.  Repair of segmental load-bearing bone defect by autologous mesenchymal stem cells and plasma-derived fibrin impregnated ceramic block results in early recovery of limb function.

Authors:  Min Hwei Ng; Suryasmi Duski; Kok Keong Tan; Mohd Reusmaazran Yusof; Kiat Cheong Low; Isa Mohamed Rose; Zahiah Mohamed; Aminuddin Bin Saim; Ruszymah Bt Hj Idrus
Journal:  Biomed Res Int       Date:  2014-07-08       Impact factor: 3.411

Review 4.  Toxicity of Nanoparticles and an Overview of Current Experimental Models.

Authors:  Haji Bahadar; Faheem Maqbool; Kamal Niaz; Mohammad Abdollahi
Journal:  Iran Biomed J       Date:  2015-08-19

Review 5.  Additive Manufacturing for Guided Bone Regeneration: A Perspective for Alveolar Ridge Augmentation.

Authors:  Patrick Rider; Željka Perić Kačarević; Said Alkildani; Sujith Retnasingh; Reinhard Schnettler; Mike Barbeck
Journal:  Int J Mol Sci       Date:  2018-10-24       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.